Age and Refraction in Predicting Myopia Progression in COVID-19

Tianjin Eye Hospital

Status

Completed

Conditions

Myopia

Refraction Error

Treatments

Other: screening

Study type

Observational

Funder types

Other

Identifiers

NCT05305274

2022018

Details and patient eligibility

About

To determine the longitudinal changes of age and refraction in predicting myopia progression with risk under the coronavirus disease 2019 (COVID-19) pandemic in a 3-year follow-up of a Chinese cohort.

Full description

This was part of the large-scale Tianjin Eye Study, a population-based cohort study that longitudinally investigates the relationship between the age, refraction, and development of childhood RE in Tianjin, China.

Enrollment

34,400 patients

Sex

All

Ages

6 to 15 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

no concurrent eye disease;
age 6-15 years.

Exclusion criteria

significant systemic illnesses
ocular conditions that could affect the corneal curvature, including congenital corneal diseases,
pterygium, keratoconus, other corneal degeneration or dystrophy conditions,
media opacity, uveitis, glaucoma
a history of intraocular surgery, refractive surgery,
neurologic or retinal diseases, current corneal refractive therapy (ortho-K),
low-dose atropine therapy for myopia control